Abbott Laboratories buy Wells Fargo & Company
Start price
05.04.23
/
50%
€93.86
Target price
05.04.24
€124.25
Performance (%)
8.89%
End price
06.04.24
€102.20
Summary
This prediction ended on 06.04.24 with a price of €102.20. With a performance of 8.89%, the BUY prediction by Wells_Fargo___Compan for Abbott Laboratories closed with a slight gain. Wells_Fargo___Compan has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. Dividends of €1.90 are taken into consideration when calculating the performance. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Abbott Laboratories | -1.587% | -1.587% | -4.766% |
iShares Core DAX® | 1.851% | 5.158% | 17.711% |
iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% |
iShares Nikkei 225® | -0.412% | -2.857% | 13.501% |
iShares S&P 500 | 1.128% | 2.485% | 29.871% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Wells Fargo & Company from $140.00 to $136.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Abbott Laboratories
Stopped prediction by Wells_Fargo___Compan for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€98.55
13.12.23
13.12.23
€112.13
13.12.24
13.12.24
-1.92%
10:48
10:48